A breast cancer diagnosis in a family member often sends shockwaves far beyond the patient. For those carrying genetic or inherited predispositions, the urgency to act on preventive measures—especially surgery—can become overwhelming. Mayo Clinic specialists provide detailed guidance on when and how to evaluate risk-reducing mastectomy, alongside other strategies proven to lower breast cancer risk.
Identifying high-risk individuals
The process begins with a thorough assessment of personal and family medical history by a specialist. Clinicians integrate multiple elements, genetic testing results, family medical records, and risk-assessment tools, to calculate an individual’s lifetime probability of developing breast cancer. Major risk factors include mutations in the BRCA1 or BRCA2 genes, a history of breast or ovarian cancer in first-degree relatives, and hormonal influences such as early onset of menstruation or delayed childbearing.
Genetic testing becomes particularly important when family members already carry known mutations or when multiple cases of breast or ovarian cancer appear across successive generations. A genetic counselor assists in interpreting these test results and advises on whether preventive actions are warranted. For individuals deemed to be at significantly higher risk, screening protocols often expand beyond annual mammograms to include breast MRI scans and more frequent imaging studies.
Risk reduction strategies: surgical, medical, and behavioral approaches
Prevention efforts fall into three broad categories. Lifestyle modifications, such as achieving and maintaining a healthy body weight, engaging in regular physical activity, and limiting alcohol consumption, can produce modest but meaningful reductions in risk. Studies indicate that combining aerobic exercise with resistance training delivers the strongest protective effect. For those at raised risk, certain medications can lower breast cancer risk by about 50%-70% in select people, though these require extended use and may not be suitable for everyone.
Among the highest-risk individuals, particularly those carrying BRCA mutations, preventive mastectomy remains the most effective intervention. A bilateral (double) mastectomy reduces the likelihood of developing breast cancer by 90% to 95%, though it does not guarantee complete protection. Because the procedure is permanent and affects body image, sensation, and daily functioning, thorough discussions with a multidisciplinary care team are essential before making a final decision.
For those pursuing surgery, the specific approach varies. A total mastectomy removes all breast tissue, resulting in a flat chest wall. In carefully selected cases, a skin-sparing or nipple-sparing mastectomy preserves some skin tissue or the nipple-areola complex, respectively. Advances in robotic-assisted surgery have expanded options for nipple-sparing procedures, enabling smaller incisions, reduced scarring, and potentially improved cosmetic and functional outcomes. Early clinical data suggest these techniques maintain equivalent cancer control while accelerating recovery.
Selecting among these options depends on individual factors. Age, menopausal status, fertility intentions, and personal values all influence the decision-making process. Consultations with a breast surgical oncologist and genetic counselor help clarify the trade-offs and ensure choices align with long-term health objectives.